Understanding GlycA: Normal vs Optimal Ranges

?What is GlycA?

GlycA is a novel composite inflammatory biomarker measured by nuclear magnetic resonance (NMR) spectroscopy, reflecting glycosylation of multiple acute-phase proteins including alpha-1-acid glycoprotein, alpha-1-antitrypsin, haptoglobin, and transferrin. Unlike hsCRP which measures one protein, GlycA integrates the chronic inflammatory signal from several proteins simultaneously. It is reported alongside the NMR LipoProfile (LP-IR, Lp-PLA2) panel.

!Why It Matters

GlycA is a stable, long-term indicator of chronic systemic inflammation with less short-term variability than hsCRP. Studies show GlycA independently predicts incident cardiovascular disease, type 2 diabetes, metabolic syndrome, and mortality beyond traditional inflammatory markers. Its composite nature makes it more representative of the chronic inflammatory state than any single acute-phase protein.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• No direct symptoms — GlycA reflects subclinical chronic inflammation
• Associated conditions: metabolic syndrome, obesity, insulin resistance
• Fatigue and malaise from underlying inflammatory burden
• Worsening cardiovascular or metabolic risk markers

How to Improve Your Levels

• 1Anti-inflammatory Mediterranean-style diet: reduces GlycA by 10–15% in clinical trials
• 2Regular aerobic exercise: each 1 MET-hour/week increase in PA lowers GlycA
• 3Achieve healthy body weight: adipose tissue is a major source of GlycA-driving inflammation
• 4Improve sleep quality: poor sleep drives acute-phase protein glycosylation
• 5Treat underlying infections, autoimmune conditions, or metabolic syndrome

When to Test

Cardiovascular risk stratification alongside standard lipid panel; metabolic syndrome evaluation; chronic inflammation workup; as part of NMR LipoProfile.

Related Biomarkers